Anthony King

I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.

My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.

I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.

My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.

Follow @https://twitter.com/AntonyJKing

Business
Bees face a barrage of chemical and environmental burdens
2021-10-20T08:30:00
Better understanding of the combined effects of multiple stress factors could help reduce pollinator decline
News
First malaria vaccine approved as hopes raised for new, better ones
2021-10-12T13:57:00
Mosquirix prevents just 30% of severe malaria cases in young children prompting a guarded welcome
Business
New antiviral impresses against Covid-19
2021-10-08T13:28:00
Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses
Research
Bees’ static buzz triggers release of floral fragrance
2021-10-01T08:07:00
Discovery reveals new nuances in pollination
News
Ivermectin debacle exposes flaws in meta-analysis methodology
2021-09-29T13:30:00
Health researchers warn that taking studies at face value is a luxury that they can no longer afford
Research
Giant molecular cage protects plastic-eating enzyme
2021-09-16T08:30:00
Caged protein withstands temperatures much hotter than its usual melting point and becomes 1000 times more resistant to solvents
Business
US grants Pfizer’s Covid-19 vaccine full approval
2021-09-02T08:30:00
WHO calls for delay to booster programmes to allow more global distribution
Research
How a single ingredient creates silky smooth chocolate without tempering
2021-08-31T15:01:00
Natural phospholipids trigger cocoa butter crystallisation into glossy, tasty, melt-in-the-mouth chocolate
Business
The multi-pronged search for Covid-19 treatments
2021-08-27T08:30:00
Drugs that block infection or reduce inflammation will complement vaccine protection
Business
Developing countries sidelined in Covid-19 vaccine scramble
2021-08-11T08:29:00
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
News
Europe raises the bar for carcinogens in artificial turf pitches
2021-08-09T13:22:00
Permissible limits for certain polycyclic aromatic hydrocarbons to fall 50-fold in 2022
Business
Regeneron’s Covid-19 antibodies help those who can’t make their own
2021-06-18T13:42:00
Regn-Cov2 reduces deaths and shortens hospitalisation for these patients, even when given at late stages of infection
Business
Alzheimer’s antibody gets surprise US approval
2021-06-16T14:32:00
Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients
Research
Protein impurities found in AstraZeneca’s Covid-19 vaccine stir debate
2021-06-15T08:30:00
Compounds might cause side effects but are unlikely to be behind extremely rare blood-clotting events
News
Hints that century-old TB vaccine offers an immune boost against Covid-19
2021-06-11T08:31:00
Small study is part of global effort examining whether the BCG jab could help in the next pandemic
Business
Why manufacturing Covid vaccines at scale is hard
2021-03-23T09:40:00
Exploring the pinch points vaccine makers face as they ramp up production
News
Green light for world’s first Sars-CoV-2 studies that will infect healthy volunteers
2021-02-24T09:30:00
UK trials will assess how well Covid-19 treatments work and if vaccines protect against new virus variants
Business
Coronavirus variants stymie success of monoclonal antibodies
2021-02-23T15:50:00
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
News
European commission to reconsider how it announces winners of Marie Curie fellowships
2021-02-17T15:23:00
Some researchers applying for the EU scheme were left in limbo over whether or not they had won an award
Business
Covid vaccination efforts bolstered by trial results from J&J and Novavax
2021-02-04T14:10:00
A miserable January ended with positive news on the vaccine front but new variants added complications

More by Anthony King